BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

754 related articles for article (PubMed ID: 19445370)

  • 1. [Limbic encephalitis--evolving concepts].
    Serratrice G; Pellissier JF; Serratrice J; De Paula A
    Bull Acad Natl Med; 2008 Nov; 192(8):1531-41; discussion 1541-2. PubMed ID: 19445370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Limbic encephalitis: the new cell membrane antigens and a proposal of clinical-immunological classification with therapeutic implications].
    Dalmau J; Bataller L
    Neurologia; 2007 Oct; 22(8):526-37. PubMed ID: 18000762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anti-VGKC antibody-associated limbic encephalitis/Morvan syndrome].
    Misawa T; Mizusawa H
    Brain Nerve; 2010 Apr; 62(4):339-45. PubMed ID: 20420173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis.
    Vincent A; Buckley C; Schott JM; Baker I; Dewar BK; Detert N; Clover L; Parkinson A; Bien CG; Omer S; Lang B; Rossor MN; Palace J
    Brain; 2004 Mar; 127(Pt 3):701-12. PubMed ID: 14960497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limbic encephalitis and variants: classification, diagnosis and treatment.
    Tüzün E; Dalmau J
    Neurologist; 2007 Sep; 13(5):261-71. PubMed ID: 17848866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical analysis of anti-Ma2-associated encephalitis.
    Dalmau J; Graus F; Villarejo A; Posner JB; Blumenthal D; Thiessen B; Saiz A; Meneses P; Rosenfeld MR
    Brain; 2004 Aug; 127(Pt 8):1831-44. PubMed ID: 15215214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-nMDA receptor encephalitis--clinical manifestations and pathophysiology].
    Iizuka T; Sakai F
    Brain Nerve; 2008 Sep; 60(9):1047-60. PubMed ID: 18807939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limbic encephalitis - a review.
    Anderson NE; Barber PA
    J Clin Neurosci; 2008 Sep; 15(9):961-71. PubMed ID: 18411052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-Ma2-associated encephalitis and paraneoplastic limbic encephalitis].
    Yamamoto T; Tsuji S
    Brain Nerve; 2010 Aug; 62(8):838-51. PubMed ID: 20714032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis.
    Bien CG; Vincent A; Barnett MH; Becker AJ; Blümcke I; Graus F; Jellinger KA; Reuss DE; Ribalta T; Schlegel J; Sutton I; Lassmann H; Bauer J
    Brain; 2012 May; 135(Pt 5):1622-38. PubMed ID: 22539258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromyotonia and limbic encephalitis sera target mature Shaker-type K+ channels: subunit specificity correlates with clinical manifestations.
    Kleopa KA; Elman LB; Lang B; Vincent A; Scherer SS
    Brain; 2006 Jun; 129(Pt 6):1570-84. PubMed ID: 16613892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates.
    Ances BM; Vitaliani R; Taylor RA; Liebeskind DS; Voloschin A; Houghton DJ; Galetta SL; Dichter M; Alavi A; Rosenfeld MR; Dalmau J
    Brain; 2005 Aug; 128(Pt 8):1764-77. PubMed ID: 15888538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voltage-gated potassium channel antibodies associated limbic encephalitis in a patient with invasive thymoma.
    Ohshita T; Kawakami H; Maruyama H; Kohriyama T; Arimura K; Matsumoto M
    J Neurol Sci; 2006 Dec; 250(1-2):167-9. PubMed ID: 17028029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical characteristics of non-herpetic limbic encephalitis].
    Shoji H
    Brain Nerve; 2010 Aug; 62(8):853-60. PubMed ID: 20714033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of acute autoimmune limbic encephalitis with negative VGKC and NMDAR antibodies.
    Modoni A; Masciullo M; Spinelli P; Marra C; Tartaglione T; Andreetta F; Tonali P; Silvestri G
    Cogn Behav Neurol; 2009 Mar; 22(1):63-6. PubMed ID: 19372772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Autoimmune limbic encephalitis with anti-NMDA receptor antibodies and ovarian teratoma: a treatable form of paraneoplastic limbic encephalitis].
    Henry C; Husson H; de Broucker T
    Rev Neurol (Paris); 2009 Jan; 165(1):70-5. PubMed ID: 18809188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous muscle activity, Morvan's syndrome and limbic encephalitis: ionic or non ionic disorders?
    Serratrice G; Serratrice J
    Acta Myol; 2011 Jun; 30(1):32-3. PubMed ID: 21842591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Limbic encephalitis: etiology, pathogenesis, diagnosis and therapy].
    Inuzuka T
    Rinsho Shinkeigaku; 2004 Nov; 44(11):799-801. PubMed ID: 15651295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potassium channel antibody-associated encephalitis with hypothalamic lesions and intestinal pseudo-obstruction.
    Sekiguchi Y; Takahashi H; Mori M; Ito S; Shimada H; Hattori T; Kuwabara S
    J Neurol Sci; 2008 Jun; 269(1-2):176-9. PubMed ID: 18378260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voltage-gated potassium channel antibodies in limbic encephalitis.
    Pozo-Rosich P; Clover L; Saiz A; Vincent A; Graus F
    Ann Neurol; 2003 Oct; 54(4):530-3. PubMed ID: 14520669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.